IBDEI0JD ; ; 18-NOV-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;NOV 18, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,26043,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26043,1,3,0)
 ;;=3^Glaucoma,Pigmentary
 ;;^UTILITY(U,$J,358.3,26043,1,4,0)
 ;;=4^365.13
 ;;^UTILITY(U,$J,358.3,26043,2)
 ;;=Pigmentary Glaucoma^51211
 ;;^UTILITY(U,$J,358.3,26044,0)
 ;;=365.20^^165^1541^26
 ;;^UTILITY(U,$J,358.3,26044,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26044,1,3,0)
 ;;=3^Glaucoma,Prim Angle Closure
 ;;^UTILITY(U,$J,358.3,26044,1,4,0)
 ;;=4^365.20
 ;;^UTILITY(U,$J,358.3,26044,2)
 ;;=^51195
 ;;^UTILITY(U,$J,358.3,26045,0)
 ;;=365.52^^165^1541^27
 ;;^UTILITY(U,$J,358.3,26045,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26045,1,3,0)
 ;;=3^Glaucoma,Pseudoexfoliation
 ;;^UTILITY(U,$J,358.3,26045,1,4,0)
 ;;=4^365.52
 ;;^UTILITY(U,$J,358.3,26045,2)
 ;;=Pseudoexfoliation Glaucoma^268771
 ;;^UTILITY(U,$J,358.3,26046,0)
 ;;=365.15^^165^1541^29
 ;;^UTILITY(U,$J,358.3,26046,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26046,1,3,0)
 ;;=3^Glaucoma,Residual Open Angle
 ;;^UTILITY(U,$J,358.3,26046,1,4,0)
 ;;=4^365.15
 ;;^UTILITY(U,$J,358.3,26046,2)
 ;;=Residual Open Angle Glaucoma^268751
 ;;^UTILITY(U,$J,358.3,26047,0)
 ;;=365.31^^165^1541^32
 ;;^UTILITY(U,$J,358.3,26047,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26047,1,3,0)
 ;;=3^Glaucoma,Steroid Induced
 ;;^UTILITY(U,$J,358.3,26047,1,4,0)
 ;;=4^365.31
 ;;^UTILITY(U,$J,358.3,26047,2)
 ;;=Steroid Induced Glaucoma^268761
 ;;^UTILITY(U,$J,358.3,26048,0)
 ;;=365.61^^165^1541^11
 ;;^UTILITY(U,$J,358.3,26048,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26048,1,3,0)
 ;;=3^Glaucoma W/Pupillary Block
 ;;^UTILITY(U,$J,358.3,26048,1,4,0)
 ;;=4^365.61
 ;;^UTILITY(U,$J,358.3,26048,2)
 ;;=Glaucoma W/Pupillary Block^268776
 ;;^UTILITY(U,$J,358.3,26049,0)
 ;;=365.23^^165^1541^13
 ;;^UTILITY(U,$J,358.3,26049,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26049,1,3,0)
 ;;=3^Glaucoma,Chr Angle Closure
 ;;^UTILITY(U,$J,358.3,26049,1,4,0)
 ;;=4^365.23
 ;;^UTILITY(U,$J,358.3,26049,2)
 ;;=^268756
 ;;^UTILITY(U,$J,358.3,26050,0)
 ;;=363.71^^165^1541^43
 ;;^UTILITY(U,$J,358.3,26050,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26050,1,3,0)
 ;;=3^Serous Choroidal Detachment
 ;;^UTILITY(U,$J,358.3,26050,1,4,0)
 ;;=4^363.71
 ;;^UTILITY(U,$J,358.3,26050,2)
 ;;=Choroidal Detachment^268699
 ;;^UTILITY(U,$J,358.3,26051,0)
 ;;=365.51^^165^1541^24
 ;;^UTILITY(U,$J,358.3,26051,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26051,1,3,0)
 ;;=3^Glaucoma,Phacolytic
 ;;^UTILITY(U,$J,358.3,26051,1,4,0)
 ;;=4^365.51
 ;;^UTILITY(U,$J,358.3,26051,2)
 ;;=Phacolytic Glaucoma^265226
 ;;^UTILITY(U,$J,358.3,26052,0)
 ;;=365.01^^165^1541^21
 ;;^UTILITY(U,$J,358.3,26052,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26052,1,3,0)
 ;;=3^Glaucoma,Open Angle Suspect
 ;;^UTILITY(U,$J,358.3,26052,1,4,0)
 ;;=4^365.01
 ;;^UTILITY(U,$J,358.3,26052,2)
 ;;=Open Angle Glaucoma Suspect^268747
 ;;^UTILITY(U,$J,358.3,26053,0)
 ;;=365.04^^165^1541^37
 ;;^UTILITY(U,$J,358.3,26053,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26053,1,3,0)
 ;;=3^Ocular Hypertension
 ;;^UTILITY(U,$J,358.3,26053,1,4,0)
 ;;=4^365.04
 ;;^UTILITY(U,$J,358.3,26053,2)
 ;;=Ocular Hypertension^85124
 ;;^UTILITY(U,$J,358.3,26054,0)
 ;;=365.03^^165^1541^44
 ;;^UTILITY(U,$J,358.3,26054,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26054,1,3,0)
 ;;=3^Steroid Responder
 ;;^UTILITY(U,$J,358.3,26054,1,4,0)
 ;;=4^365.03
 ;;^UTILITY(U,$J,358.3,26054,2)
 ;;=^268749
 ;;^UTILITY(U,$J,358.3,26055,0)
 ;;=366.11^^165^1541^41
 ;;^UTILITY(U,$J,358.3,26055,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26055,1,3,0)
 ;;=3^Pseudoexfoliation w/o Glaucoma
 ;;^UTILITY(U,$J,358.3,26055,1,4,0)
 ;;=4^366.11
 ;;^UTILITY(U,$J,358.3,26055,2)
 ;;=^265538
 ;;^UTILITY(U,$J,358.3,26056,0)
 ;;=365.02^^165^1541^1
 ;;^UTILITY(U,$J,358.3,26056,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26056,1,3,0)
 ;;=3^Anatomic Narrow Angle
 ;;^UTILITY(U,$J,358.3,26056,1,4,0)
 ;;=4^365.02
 ;;^UTILITY(U,$J,358.3,26056,2)
 ;;=Anatomic Narrow Angle^268748
 ;;^UTILITY(U,$J,358.3,26057,0)
 ;;=364.53^^165^1541^39
 ;;^UTILITY(U,$J,358.3,26057,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26057,1,3,0)
 ;;=3^Pigment Dispersion w/o Glauc
 ;;^UTILITY(U,$J,358.3,26057,1,4,0)
 ;;=4^364.53
 ;;^UTILITY(U,$J,358.3,26057,2)
 ;;=^268720
 ;;^UTILITY(U,$J,358.3,26058,0)
 ;;=364.42^^165^1541^42
 ;;^UTILITY(U,$J,358.3,26058,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26058,1,3,0)
 ;;=3^Rubeosis Iridis w/o Glaucoma
 ;;^UTILITY(U,$J,358.3,26058,1,4,0)
 ;;=4^364.42
 ;;^UTILITY(U,$J,358.3,26058,2)
 ;;=Rubeosis Iridis w/o Glaucoma^268716
 ;;^UTILITY(U,$J,358.3,26059,0)
 ;;=364.77^^165^1541^2
 ;;^UTILITY(U,$J,358.3,26059,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26059,1,3,0)
 ;;=3^Angle Recession w/o Glauc
 ;;^UTILITY(U,$J,358.3,26059,1,4,0)
 ;;=4^364.77
 ;;^UTILITY(U,$J,358.3,26059,2)
 ;;=Angle Recession w/o Glauc^268743
 ;;^UTILITY(U,$J,358.3,26060,0)
 ;;=368.40^^165^1541^45
 ;;^UTILITY(U,$J,358.3,26060,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26060,1,3,0)
 ;;=3^Visual Field Defect
 ;;^UTILITY(U,$J,358.3,26060,1,4,0)
 ;;=4^368.40
 ;;^UTILITY(U,$J,358.3,26060,2)
 ;;=Visual Field Defect^126859
 ;;^UTILITY(U,$J,358.3,26061,0)
 ;;=363.70^^165^1541^4
 ;;^UTILITY(U,$J,358.3,26061,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26061,1,3,0)
 ;;=3^Choroidal Detachment NOS
 ;;^UTILITY(U,$J,358.3,26061,1,4,0)
 ;;=4^363.70
 ;;^UTILITY(U,$J,358.3,26061,2)
 ;;=^276841
 ;;^UTILITY(U,$J,358.3,26062,0)
 ;;=365.24^^165^1541^28
 ;;^UTILITY(U,$J,358.3,26062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26062,1,3,0)
 ;;=3^Glaucoma,Residual Angle Closure
 ;;^UTILITY(U,$J,358.3,26062,1,4,0)
 ;;=4^365.24
 ;;^UTILITY(U,$J,358.3,26062,2)
 ;;=^268758
 ;;^UTILITY(U,$J,358.3,26063,0)
 ;;=365.65^^165^1541^34
 ;;^UTILITY(U,$J,358.3,26063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26063,1,3,0)
 ;;=3^Glaucoma,Traumatic
 ;;^UTILITY(U,$J,358.3,26063,1,4,0)
 ;;=4^365.65
 ;;^UTILITY(U,$J,358.3,26063,2)
 ;;=^268780
 ;;^UTILITY(U,$J,358.3,26064,0)
 ;;=365.89^^165^1541^23
 ;;^UTILITY(U,$J,358.3,26064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26064,1,3,0)
 ;;=3^Glaucoma,Oth Specified
 ;;^UTILITY(U,$J,358.3,26064,1,4,0)
 ;;=4^365.89
 ;;^UTILITY(U,$J,358.3,26064,2)
 ;;=^88069
 ;;^UTILITY(U,$J,358.3,26065,0)
 ;;=365.05^^165^1541^38
 ;;^UTILITY(U,$J,358.3,26065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26065,1,3,0)
 ;;=3^Opn Ang w/ brdrlne fnd-Hi Risk
 ;;^UTILITY(U,$J,358.3,26065,1,4,0)
 ;;=4^365.05
 ;;^UTILITY(U,$J,358.3,26065,2)
 ;;=^340511
 ;;^UTILITY(U,$J,358.3,26066,0)
 ;;=365.06^^165^1541^40
 ;;^UTILITY(U,$J,358.3,26066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26066,1,3,0)
 ;;=3^Prim Ang Clos w/o Glauc Dmg
 ;;^UTILITY(U,$J,358.3,26066,1,4,0)
 ;;=4^365.06
 ;;^UTILITY(U,$J,358.3,26066,2)
 ;;=^340512
 ;;^UTILITY(U,$J,358.3,26067,0)
 ;;=365.70^^165^1541^31
 ;;^UTILITY(U,$J,358.3,26067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26067,1,3,0)
 ;;=3^Glaucoma,Stage NOS
 ;;^UTILITY(U,$J,358.3,26067,1,4,0)
 ;;=4^365.70
 ;;^UTILITY(U,$J,358.3,26067,2)
 ;;=^340609
 ;;^UTILITY(U,$J,358.3,26068,0)
 ;;=365.71^^165^1541^17
 ;;^UTILITY(U,$J,358.3,26068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26068,1,3,0)
 ;;=3^Glaucoma,Mild Stage
 ;;^UTILITY(U,$J,358.3,26068,1,4,0)
 ;;=4^365.71
 ;;^UTILITY(U,$J,358.3,26068,2)
 ;;=^340513
 ;;^UTILITY(U,$J,358.3,26069,0)
 ;;=365.72^^165^1541^18
 ;;^UTILITY(U,$J,358.3,26069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26069,1,3,0)
 ;;=3^Glaucoma,Moderate Stage
 ;;^UTILITY(U,$J,358.3,26069,1,4,0)
 ;;=4^365.72
 ;;^UTILITY(U,$J,358.3,26069,2)
 ;;=^340514
 ;;^UTILITY(U,$J,358.3,26070,0)
 ;;=365.73^^165^1541^30
 ;;^UTILITY(U,$J,358.3,26070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26070,1,3,0)
 ;;=3^Glaucoma,Severe Stage
 ;;^UTILITY(U,$J,358.3,26070,1,4,0)
 ;;=4^365.73
 ;;^UTILITY(U,$J,358.3,26070,2)
 ;;=^340515
 ;;^UTILITY(U,$J,358.3,26071,0)
 ;;=365.74^^165^1541^14
 ;;^UTILITY(U,$J,358.3,26071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26071,1,3,0)
 ;;=3^Glaucoma,Indeterm Stage
 ;;^UTILITY(U,$J,358.3,26071,1,4,0)
 ;;=4^365.74
 ;;^UTILITY(U,$J,358.3,26071,2)
 ;;=^340516
 ;;^UTILITY(U,$J,358.3,26072,0)
 ;;=V19.11^^165^1541^5
 ;;^UTILITY(U,$J,358.3,26072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26072,1,3,0)
 ;;=3^Family Hx Glaucoma
 ;;^UTILITY(U,$J,358.3,26072,1,4,0)
 ;;=4^V19.11
 ;;^UTILITY(U,$J,358.3,26072,2)
 ;;=^340617
 ;;^UTILITY(U,$J,358.3,26073,0)
 ;;=V19.19^^165^1541^6
 ;;^UTILITY(U,$J,358.3,26073,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26073,1,3,0)
 ;;=3^Family Hx Oth Spec Eye Disord
 ;;^UTILITY(U,$J,358.3,26073,1,4,0)
 ;;=4^V19.19
 ;;^UTILITY(U,$J,358.3,26073,2)
 ;;=^340618
 ;;^UTILITY(U,$J,358.3,26074,0)
 ;;=365.62^^165^1541^8
 ;;^UTILITY(U,$J,358.3,26074,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26074,1,3,0)
 ;;=3^Glauc Assoc w/ Ocular Inflamm
 ;;^UTILITY(U,$J,358.3,26074,1,4,0)
 ;;=4^365.62
 ;;^UTILITY(U,$J,358.3,26074,2)
 ;;=^268777
 ;;^UTILITY(U,$J,358.3,26075,0)
 ;;=365.00^^165^1541^33
 ;;^UTILITY(U,$J,358.3,26075,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26075,1,3,0)
 ;;=3^Glaucoma,Suspects
 ;;^UTILITY(U,$J,358.3,26075,1,4,0)
 ;;=4^365.00
 ;;^UTILITY(U,$J,358.3,26075,2)
 ;;=^97584
 ;;^UTILITY(U,$J,358.3,26076,0)
 ;;=365.60^^165^1541^10
 ;;^UTILITY(U,$J,358.3,26076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26076,1,3,0)
 ;;=3^Glauc w/ Unspec Ocular D/O
 ;;^UTILITY(U,$J,358.3,26076,1,4,0)
 ;;=4^365.60
 ;;^UTILITY(U,$J,358.3,26076,2)
 ;;=^268775
 ;;^UTILITY(U,$J,358.3,26077,0)
 ;;=365.9^^165^1541^35
 ;;^UTILITY(U,$J,358.3,26077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26077,1,3,0)
 ;;=3^Glaucoma,Unspec
 ;;^UTILITY(U,$J,358.3,26077,1,4,0)
 ;;=4^365.9
 ;;^UTILITY(U,$J,358.3,26077,2)
 ;;=^51160
 ;;^UTILITY(U,$J,358.3,26078,0)
 ;;=365.22^^165^1541^12
 ;;^UTILITY(U,$J,358.3,26078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,26078,1,3,0)
 ;;=3^Glaucoma,Acute Angle Closure
 ;;^UTILITY(U,$J,358.3,26078,1,4,0)
 ;;=4^365.22
